Internal & Hospital Medicine #7001 Publications, presentations, and references available upon request. Contact Dora: dmancias@expertwitnessdoctors.com 512-689-6879 EDUCATION 1994 Internal Medicine Residency Central Texas Medical Foundation Brackenridge Hospital ( now Dell Seton Medical Center at UT Austin ) 1991 Doctor of Osteopathic Medicine University of North Texas Health Science Center Texas College of Osteopathic Medicine Fort Worth, Texas 1985 Bachelor of Arts Plan II Honors Program University of Texas at Austin CERTIFICATIONS 1994, 2004, 2014 Internal Medicine American Board of Internal Medicine 2008 Hospice and Palliative Medicine American Board of Internal Medicine ( due for routine recertification 2018) LICENSURE ACADEMIC EXPERIENCE Texas Medical Board 1992 1998-present Medical Students Residents Nurse Practitioner Candidates Pharmacy Students ( from various academic programs )
PROFESSIONAL EXPERIENCE 2011-present 2011-present 2003-present HCC, PLLC Administrator Fulltime Hospitalist Internal Med Solutions, LLC Administrator Owner HCC, PLLC Hospitalist Program Development/Quality Consultant 1997-2011 Hospital Internists of Austin, PA Board of Directors Fulltime Hospital Based Internist/Hospitalist 1997-2004 Hospital Internists of Austin, PA Co-Founder Vice-President Chief Operating Officer 1994-1997 Solo/Independent Hospitalist Practice 2016-present Hospice Medical Director CIMA Hospice 2014-2015 Hospice Medical Director Robinson Creek Home Hospice 2004-2013 Central Texas Palliative Care Consultants Associate Medical Director Hospice Austin
2008-2017 TEKTON Research Clinical Investigator/Research AWARDS/ADVOCACY/SERVICE 2017 Fellowship American College of Physicians 2017 Texas ACP Emerald Service Award GIMSPP (Teaching Award) 2014 Texas PM & R Society Certificate of Recognition For Outstanding Service to Rehabilitation Patients 2007 Texas ACP Decade of Service Award GIMSPP (Teaching Award) 2013-2018 TMA Council on Health Service Organizations 2015-2017 TEXPAC District Co-Chair 2008-2015 Travis County Medical Society ( TCMS) Executive Board 2015 Immediate Past President 2014 President 2013 President-Elect 2012 Secretary/Treasurer 2008-2011 Member at-large 2012-2015 Central Texas Regional Blood Center Board 2007-2014 Alternate Delegate to TMA for TCMS 2014-present Delegate to TMA for TCMS 2008-2017 TCMS Volunteer Physicals for Austin Ind. School District 1996 present Various Hospital(s) Site Committees, including: Chief of Internal Medicine Department(s) Chief of Hospitalist Service(s) Chief of Staff/MEC(s) Governing Board(s) Critical Care Council Network Acute and Critical Care Committee Network Musculoskeletal Programs Committee Infection Control Committee(s) Complex Medical Care Program Director
Disaster Preparedness Committee(s) Pharmacy and Therapeutics Committee(s) QA/QUAPI/Performance Improvement Committee(s) Peer Review Committee(s) Disruptive Physician / Provider Committee(s) Bundle Programs Initiative EHR Implementation Champion MEMBERSHIPS RESEARCH ACTIVITIES Travis County Medical Society Texas Medical Association / TEXPAC American Medical Association American College of Physicians Texas Chapter of the American College of Physicians Texas Club of Internists Texas Osteopathic Medical Association A Phase 2B, Double-Blind, Double-Dummy, Randomized, Parallel Group Study to Evaluate the Safety and Efficacy of Twice Daily Dosing and Once Daily Dosing of XXXX in Subject Undergoing Primary Elective Knee Arthroplasty A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare XXXX bid and qd Doses and XXXX for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery A PHASE 3 RANDOMIZED, DOUBLE-BLIND PLACEBO AND NAPROXEN CONTROLLED MULTICENTER STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF XXXX IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE OR HIP A Phase 3, Multicenter, Randomized, Long Term Study of XXXX in Patients with Osteoarthritis of the Knee or Hip A Phase 3, Multicenter, Randomized, Double-Blind, Controlled Study of The Long Term Analgesic Efficacy and Safety of XXXX Alone or in
Combination with Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Versus NSAIDS Alone, in Patients Osteoarthritis of the Knee or Hip A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Analgesic Efficacy and Safety of Subcutaneous Administration of XXXX in Patients with Osteoarthritis of the Knee A Phase 3, Multicenter, Randomized Long Term Study of the Safety of the Subcutaneous Administration of XXXX in Patients with Osteoarthritis of the Knee